BEGIN:VCALENDAR PRODID:-//Microsoft Corporation//Outlook 16.0 MIMEDIR//EN VERSION:2.0 METHOD:PUBLISH X-MS-OLK-FORCEINSPECTOROPEN:TRUE BEGIN:VTIMEZONE TZID:Eastern Standard Time BEGIN:STANDARD DTSTART:16011104T020000 RRULE:FREQ=YEARLY;BYDAY=1SU;BYMONTH=11 TZOFFSETFROM:-0400 TZOFFSETTO:-0500 END:STANDARD BEGIN:DAYLIGHT DTSTART:16010311T020000 RRULE:FREQ=YEARLY;BYDAY=2SU;BYMONTH=3 TZOFFSETFROM:-0500 TZOFFSETTO:-0400 END:DAYLIGHT END:VTIMEZONE BEGIN:VEVENT CLASS:PUBLIC CREATED:20210505T155215Z DESCRIPTION:Monday\, May 24th at 7:00 p.m. EDT\nAs a result of participatin g in this activity\, learners will be able to: Review the outcomes for di fferent subsets of patients with pancreatic cancer\, recognize the potenti al relevance of neoadjuvant chemotherapy and radiotherapy for resectable a nd unresectable pancreatic cancer\, and discuss the use of evidence-based national guidelines and prognostic indicators\, such as the AJCC staging s ystem\nThe target audience for this presentation: medical oncologists\, su rgical oncologists\, radiation oncologists\, gastroenterologists\nWatch LI VE\nhttps://cme.tgh.org/videos/updates-in-the-multidisciplinary-management -of-localized-pancreatic-cancer\n \n \n DTEND;TZID="Eastern Standard Time":20210524T200000 DTSTAMP:20200323T203953Z DTSTART;TZID="Eastern Standard Time":20210524T190000 LAST-MODIFIED:20210505T155215Z LOCATION:https://cme.tgh.org/videos/updates-in-the-multidisciplinary-manage ment-of-localized-pancreatic-cancer PRIORITY:5 SEQUENCE:0 SUMMARY;LANGUAGE=en-us:[LIVE CME] Updates in the Multidisciplinary Manageme nt of Localized Pancreatic Cancer TRANSP:OPAQUE UID:040000008200E00074C5B7101A82E00800000000B0F9FF323101D601000000000000000 0100000003759C7553D795D42AC654D8F56E49D63 X-ALT-DESC;FMTTYPE=text/html:
Monday\, May 24th at 7:00 p.
m. EDT
As a result of participating in this activity\, learners wil
l be able to:  \;Review the outcomes for differe
nt subsets of patients with pancreatic cancer\, recognize the potential re
levance of neoadjuvant chemotherapy and radiotherapy for resectable and unresectable pancreatic cancer\, and discuss the u
se of evidence-based national guidelines and prognostic indicators\, such
as the AJCC staging system
The target audience for this presentation: \;medical oncologists\, surgical oncologists\, radia
tion oncologists\, gastroenterologists
Watch LIVE